A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic Syndrome

Clinical trial NCT01880437 · TERMINATED

Trial details

NCT number: NCT01880437
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes, Myelogenous Leukemia, Acute

Start date: 2013-09-01
Primary completion: 2014-11-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.